Reply to “The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design” and “Self-reported side effects following COVID-19 vaccination in athletes: Correspondence”
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Human Vaccines & Immunotherapeutics - 19(2023), 2 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Klara Komici [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Covid-19 vaccines, athletes |
|---|
| doi: |
10.1080/21645515.2023.2260534 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ096989017 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ096989017 | ||
| 003 | DE-627 | ||
| 005 | 20240413165623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21645515.2023.2260534 |2 doi | |
| 035 | |a (DE-627)DOAJ096989017 | ||
| 035 | |a (DE-599)DOAJ9a874bbfd35c46b0bad674c25f8f713a | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-607 | |
| 050 | 0 | |a RM1-950 | |
| 100 | 0 | |a Klara Komici |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply to “The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design” and “Self-reported side effects following COVID-19 vaccination in athletes: Correspondence” |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 4 | |a sars-cov-2 infection | |
| 650 | 4 | |a sars-cov-2 vaccines | |
| 650 | 4 | |a covid-19 vaccines, athletes | |
| 650 | 4 | |a side effects | |
| 653 | 0 | |a Immunologic diseases. Allergy | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 700 | 0 | |a Sofia Verderosa |e verfasserin |4 aut | |
| 700 | 0 | |a Fabio D’Amico |e verfasserin |4 aut | |
| 700 | 0 | |a Germano Guerra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Human Vaccines & Immunotherapeutics |d Taylor & Francis Group, 2022 |g 19(2023), 2 |w (DE-627)DOAJ000147656 |x 2164554X |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2023 |g number:2 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/21645515.2023.2260534 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9a874bbfd35c46b0bad674c25f8f713a |z kostenfrei |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21645515.2023.2260534 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2164-5515 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2164-554X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2023 |e 2 | ||